rifabutin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Rifabutin.
| Product ID | 68180-285_29e1eb82-27e2-44ac-af33-20d749f8d2c0 |
| NDC | 68180-285 |
| Product Type | Human Prescription Drug |
| Proprietary Name | rifabutin |
| Generic Name | Rifabutin |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-03-26 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090033 |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Substance Name | RIFABUTIN |
| Active Ingredient Strength | 150 mg/1 |
| Pharm Classes | Rifamycin Antimycobacterial [EPC],Rifamycins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2014-03-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA090033 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-03-26 |
| Marketing Category | ANDA |
| Application Number | ANDA090033 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-03-26 |
| Ingredient | Strength |
|---|---|
| RIFABUTIN | 150 mg/1 |
| SPL SET ID: | 4be9cc3f-0016-4426-a700-574b45ce245b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10135-738 | Rifabutin | Rifabutin |
| 59762-1350 | Rifabutin | rifabutin |
| 60687-198 | rifabutin | rifabutin |
| 68180-285 | rifabutin | rifabutin |
| 70954-041 | Rifabutin | Rifabutin |
| 0013-5301 | Mycobutin | rifabutin |
| 55695-010 | Mycobutin | rifabutin |